Total liabilities · 2011–2025
Alnylam Pharmaceuticals total liabilities
$4.2B+0.1% · FY2025
Alnylam Pharmaceuticals (ALNY) reported $4.2B in total liabilities for fiscal 2025, +0.1% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $4.2B | +0.1% | Open → |
| FY20242024-12-31 | $4.2B | +3.0% | Open → |
| FY20232023-12-31 | $4.1B | +9.3% | Open → |
| FY20222022-12-31 | $3.7B | +21.3% | Open → |
| FY20212021-12-31 | $3.1B | +27.8% | Open → |
| FY20202020-12-31 | $2.4B | +150.0% | Open → |
| FY20192019-12-31 | $956M | +250.6% | Open → |
| FY20182018-12-31 | $273M | +19.5% | Open → |
| FY20172017-12-31 | $228M | −33.4% | Open → |
| FY20162016-12-31 | $343M | +181.3% | Open → |
| FY20152015-12-31 | $122M | −15.0% | Open → |
| FY20142014-12-31 | $143M | −4.6% | Open → |
| FY20132013-12-31 | $150M | −2.1% | Open → |
| FY20122012-12-31 | $153M | −6.4% | Open → |
| FY20112011-12-31 | $164M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +26.0%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Alnylam Pharmaceuticals total liabilities |url=https://companiesranked.com/en/company/alnylam-pharmaceuticals/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Alnylam Pharmaceuticals total liabilities. CompaniesRanked. https://companiesranked.com/en/company/alnylam-pharmaceuticals/total-liabilitiesBibTeX
@misc{companiesranked-en-company-alnylam-pharmaceuticals-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Alnylam Pharmaceuticals total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/alnylam-pharmaceuticals/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001178670-26-000062 · July 30, 2026
{{cite web |title=Alnylam Pharmaceuticals total liabilities — 10-Q (0001178670-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1178670/000117867026000062/alny-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.